Friday, 28 July 2017

Disposable Blood Bags Disposes Chances of Contamination

Rise in chronic diseases has created the need for devices that can contain the contamination. Disposable blood bags are a vital component used in hospitals and ambulatory surgery centers.

Advantages of Disposable Blood Bags

Disposable blood bags are biomedical products made primarily from polyvinyl chloride (PVC) and other plastics. They are employed in blood transfusion and other surgical procedures. Blood banks use them for storage and transportation of blood and blood components such as White Blood Cells (WBCs), Red Blood Cells (RBCs), and platelets.

Disposable Blood bags Market

Blood bags are efficient for storage and preservation of blood. It was stored in sterilized glass containers that are needed to be cleaned before usage. Hospitals use data models based on genetic engineering before acquiring blood bags to reduce expenses. Recent reports of blood contamination with PVC bags have forced manufactures to look for safer alternatives.

Plasticizer Free Blood Bags

In an attempt to retain existing customers and adhere to stringent governmental policies, Macopharma has decided to employ its proprietary additive Diisononylcyclohexane Dicarboxylate (DINCH) to manufacture disposable blood bags. It is claimed to have no potential of cancer and nearly 75% reduction in the risk of leakage. It can reportedly reduce leaching into blood components by over 80%.

Eastman Chemicals has also developed an additive yo substitute for di-2-ethylhexyl terephthalate (DEHT) containers. It can reduce hemolysis and can break down RBCs. The recent outbreak of Zika virus in the United States has increased the demand for blood transfusion bags. Improved transfusion technologies and changes in product designs are expected to contribute towards market growth.

Market Overview

The disposable blood bags market is anticipated to gain lucrative revenue by 2022, according to a report available on Radiant Insights, Inc. It is expected to display a respectable CAGR during the forecast period (2012 to 2022). High cases of accidents and chronic blood disorders are the key market drivers. Continuous requirement from doctors and clinicians is expected to drive the United Stated market.

Some of the key market players are Fresenius SE & Co. KGaA, Genesis BPS, Macopharma, and Terumo Corporation.


Michelle Thoras   
Radiant Insights, Inc
San Francisco, CA 94105
Phone: 1-415-349-0054
Toll Free: 1-888-928-9744

No comments:

Post a Comment